4//SEC Filing
ABALLI JOHN 4
Accession 0001274737-22-000083
CIK 0001274737other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 9:00 AM ET
Size
5.0 KB
Accession
0001274737-22-000083
Insider Transaction Report
Form 4
EXAGEN INC.XGN
ABALLI JOHN
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-12-08$2.68/sh+90,000$241,200→ 440,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.75, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4.
Documents
Issuer
EXAGEN INC.
CIK 0001274737
Entity typeother
Related Parties
1- filerCIK 0001843113
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 9:00 AM ET
- Size
- 5.0 KB